477 related articles for article (PubMed ID: 24117156)
1. JNK signalling in cancer: in need of new, smarter therapeutic targets.
Bubici C; Papa S
Br J Pharmacol; 2014 Jan; 171(1):24-37. PubMed ID: 24117156
[TBL] [Abstract][Full Text] [Related]
2. JNK signaling as a target for anticancer therapy.
Abdelrahman KS; Hassan HA; Abdel-Aziz SA; Marzouk AA; Narumi A; Konno H; Abdel-Aziz M
Pharmacol Rep; 2021 Apr; 73(2):405-434. PubMed ID: 33710509
[TBL] [Abstract][Full Text] [Related]
3. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases.
Kumar A; Singh UK; Kini SG; Garg V; Agrawal S; Tomar PK; Pathak P; Chaudhary A; Gupta P; Malik A
Future Med Chem; 2015; 7(15):2065-86. PubMed ID: 26505831
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in the design, study, and development of c-Jun N-terminal kinase inhibitors as anticancer agents.
Messoussi A; Feneyrolles C; Bros A; Deroide A; Daydé-Cazals B; Chevé G; Van Hijfte N; Fauvel B; Bougrin K; Yasri A
Chem Biol; 2014 Nov; 21(11):1433-43. PubMed ID: 25442375
[TBL] [Abstract][Full Text] [Related]
5. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
Gehringer M; Muth F; Koch P; Laufer SA
Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibitors for JNK signalling: a potential targeted therapy in cancer.
Wu Q; Wu W; Jacevic V; Franca TCC; Wang X; Kuca K
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):574-583. PubMed ID: 31994958
[TBL] [Abstract][Full Text] [Related]
7. The functional contrariety of JNK.
Bode AM; Dong Z
Mol Carcinog; 2007 Aug; 46(8):591-8. PubMed ID: 17538955
[TBL] [Abstract][Full Text] [Related]
8. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of c-Jun N-terminal kinases: JuNK no more?
Bogoyevitch MA; Arthur PG
Biochim Biophys Acta; 2008 Jan; 1784(1):76-93. PubMed ID: 17964301
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic promise of JNK ATP-noncompetitive inhibitors.
Bogoyevitch MA
Trends Mol Med; 2005 May; 11(5):232-9. PubMed ID: 15882611
[TBL] [Abstract][Full Text] [Related]
11. Non-kinase targeting of oncogenic c-Jun N-terminal kinase (JNK) signaling: the future of clinically viable cancer treatments.
Latham SL; O'Donnell YEI; Croucher DR
Biochem Soc Trans; 2022 Dec; 50(6):1823-1836. PubMed ID: 36454622
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration.
Barnat M; Enslen H; Propst F; Davis RJ; Soares S; Nothias F
J Neurosci; 2010 Jun; 30(23):7804-16. PubMed ID: 20534829
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.
Zhu Y; Shuai W; Zhao M; Pan X; Pei J; Wu Y; Bu F; Wang A; Ouyang L; Wang G
J Med Chem; 2022 Mar; 65(5):3758-3775. PubMed ID: 35200035
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors.
Li G; Qi W; Li X; Zhao J; Luo M; Chen J
Curr Med Chem; 2021; 28(3):607-627. PubMed ID: 32039671
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
[TBL] [Abstract][Full Text] [Related]
16. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage.
Waetzig V; Herdegen T
Trends Pharmacol Sci; 2005 Sep; 26(9):455-61. PubMed ID: 16054242
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
18. The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer.
Hammouda MB; Ford AE; Liu Y; Zhang JY
Cells; 2020 Apr; 9(4):. PubMed ID: 32252279
[TBL] [Abstract][Full Text] [Related]
19. The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting.
Bogoyevitch MA
Bioessays; 2006 Sep; 28(9):923-34. PubMed ID: 16937364
[TBL] [Abstract][Full Text] [Related]
20. Specific regulation of JNK signalling by the novel rat MKK7gamma1 isoform.
Haeusgen W; Herdegen T; Waetzig V
Cell Signal; 2010 Nov; 22(11):1761-72. PubMed ID: 20633641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
